398 related articles for article (PubMed ID: 31691195)
1. The Role of Lipidomics in Autism Spectrum Disorder.
El-Ansary A; Chirumbolo S; Bhat RS; Dadar M; Ibrahim EM; Bjørklund G
Mol Diagn Ther; 2020 Feb; 24(1):31-48. PubMed ID: 31691195
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of selected biomarkers related to metabolism and oxidative stress in children with autism spectrum disorder.
El-Ansary A; Bjørklund G; Chirumbolo S; Alnakhli OM
Metab Brain Dis; 2017 Aug; 32(4):1209-1221. PubMed ID: 28497358
[TBL] [Abstract][Full Text] [Related]
3. Novel biomarkers of metabolic dysfunction is autism spectrum disorder: potential for biological diagnostic markers.
Khemakhem AM; Frye RE; El-Ansary A; Al-Ayadhi L; Bacha AB
Metab Brain Dis; 2017 Dec; 32(6):1983-1997. PubMed ID: 28831647
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers in autism spectrum disorders: Current progress.
Shen L; Liu X; Zhang H; Lin J; Feng C; Iqbal J
Clin Chim Acta; 2020 Mar; 502():41-54. PubMed ID: 31857069
[TBL] [Abstract][Full Text] [Related]
5. Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder.
Qasem H; Al-Ayadhi L; Bjørklund G; Chirumbolo S; El-Ansary A
Metab Brain Dis; 2018 Aug; 33(4):1141-1153. PubMed ID: 29569150
[TBL] [Abstract][Full Text] [Related]
6. The Potential of Salivary Lipid-Based Cannabis-Responsive Biomarkers to Evaluate Medical Cannabis Treatment in Children with Autism Spectrum Disorder.
Siani-Rose M; McKee R; Cox S; Goldstein B; Abrams D; Taylor M; Kurek I
Cannabis Cannabinoid Res; 2023 Aug; 8(4):642-656. PubMed ID: 35343818
[No Abstract] [Full Text] [Related]
7. VLDL-specific increases of fatty acids in autism spectrum disorder correlate with social interaction.
Usui N; Iwata K; Miyachi T; Takagai S; Wakusawa K; Nara T; Tsuchiya KJ; Matsumoto K; Kurita D; Kameno Y; Wakuda T; Takebayashi K; Iwata Y; Fujioka T; Hirai T; Toyoshima M; Ohnishi T; Toyota T; Maekawa M; Yoshikawa T; Maekawa M; Nakamura K; Tsujii M; Sugiyama T; Mori N; Matsuzaki H
EBioMedicine; 2020 Aug; 58():102917. PubMed ID: 32739868
[TBL] [Abstract][Full Text] [Related]
8. Phospholipidomics of peripheral blood mononuclear cells (PBMCs): the tricky case of children with autism spectrum disorder (ASD) and their healthy siblings.
Ventura G; Calvano CD; Porcelli V; Palmieri L; De Giacomo A; Xu Y; Goodacre R; Palmisano F; Cataldi TRI
Anal Bioanal Chem; 2020 Oct; 412(25):6859-6874. PubMed ID: 32737553
[TBL] [Abstract][Full Text] [Related]
9. Relationship between absolute and relative ratios of glutamate, glutamine and GABA and severity of autism spectrum disorder.
Al-Otaish H; Al-Ayadhi L; Bjørklund G; Chirumbolo S; Urbina MA; El-Ansary A
Metab Brain Dis; 2018 Jun; 33(3):843-854. PubMed ID: 29397522
[TBL] [Abstract][Full Text] [Related]
10. Autism spectrum disorder (ASD) - biomarkers of oxidative stress and methylation and transsulfuration cycle.
Waligóra A; Waligóra S; Kozarska M; Damasiewicz-Bodzek A; Gorczyca P; Tyrpień-Golder K
Psychiatr Pol; 2019 Aug; 53(4):771-788. PubMed ID: 31760409
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics of autism spectrum disorders: early insights regarding mammalian-microbial cometabolites.
Mussap M; Noto A; Fanos V
Expert Rev Mol Diagn; 2016 Aug; 16(8):869-81. PubMed ID: 27310602
[TBL] [Abstract][Full Text] [Related]
12.
Correia BSB; de Moraes Pontes JG; Nani JVS; Villalta F; Mor NC; Bordini D; Brunoni D; Brentani H; Mari JJ; Hayashi MAF; Tasic L
ACS Chem Neurosci; 2023 Mar; 14(6):1137-1145. PubMed ID: 36808953
[TBL] [Abstract][Full Text] [Related]
13. In the search for reliable biomarkers for the early diagnosis of autism spectrum disorder: the role of vitamin D.
El-Ansary A; Cannell JJ; Bjørklund G; Bhat RS; Al Dbass AM; Alfawaz HA; Chirumbolo S; Al-Ayadhi L
Metab Brain Dis; 2018 Jun; 33(3):917-931. PubMed ID: 29497932
[TBL] [Abstract][Full Text] [Related]
14. The use of data independent acquisition based proteomic analysis and machine learning to reveal potential biomarkers for autism spectrum disorder.
Zhang H; Tang X; Feng C; Gao Y; Hong Q; Zhang J; Zhang X; Zheng Q; Lin J; Liu X; Shen L
J Proteomics; 2023 Apr; 278():104872. PubMed ID: 36898611
[TBL] [Abstract][Full Text] [Related]
15. Autism Spectrum Disorders - Diagnosis and Management.
Mukherjee SB
Indian J Pediatr; 2017 Apr; 84(4):307-314. PubMed ID: 28101829
[TBL] [Abstract][Full Text] [Related]
16. Identification of developmental disorders including autism spectrum disorder using salivary miRNAs in children from Bosnia and Herzegovina.
Sehovic E; Spahic L; Smajlovic-Skenderagic L; Pistoljevic N; Dzanko E; Hajdarpasic A
PLoS One; 2020; 15(4):e0232351. PubMed ID: 32353026
[TBL] [Abstract][Full Text] [Related]
17. Targeted metabolomics highlights perturbed metabolism in the brain of autism spectrum disorder sufferers.
Graham SF; Turkoglu O; Yilmaz A; Ustun I; Ugur Z; Bjorndhal T; Han B; Mandal R; Wishart D; Bahado-Singh RO
Metabolomics; 2020 Apr; 16(5):59. PubMed ID: 32333121
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol metabolism pathway in autism spectrum disorder: From animal models to clinical observations.
Lin J; de Rezende VL; de Aguiar da Costa M; de Oliveira J; Gonçalves CL
Pharmacol Biochem Behav; 2023 Feb; 223():173522. PubMed ID: 36717034
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.
Rose S; Niyazov DM; Rossignol DA; Goldenthal M; Kahler SG; Frye RE
Mol Diagn Ther; 2018 Oct; 22(5):571-593. PubMed ID: 30039193
[TBL] [Abstract][Full Text] [Related]
20. Oxidative Stress in Autism Spectrum Disorder.
Bjørklund G; Meguid NA; El-Bana MA; Tinkov AA; Saad K; Dadar M; Hemimi M; Skalny AV; Hosnedlová B; Kizek R; Osredkar J; Urbina MA; Fabjan T; El-Houfey AA; Kałużna-Czaplińska J; Gątarek P; Chirumbolo S
Mol Neurobiol; 2020 May; 57(5):2314-2332. PubMed ID: 32026227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
